SCHEMBL1124307

SCHEMBL1124307

NCC(O)(CN)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5344219 0.79
SCHEMBL8366 0.76
SCHEMBL16155386 0.76
SCHEMBL23128914 0.76
SCHEMBL452399 0.76 FDPS (0.46)
SCHEMBL55434 0.74
SCHEMBL10400437 0.73
SCHEMBL5889690 0.73
Hydroxyamine SCHEMBL16774690 0.73 FDPS (0.36)
Ammonia Solution, Strong SCHEMBL9336079 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110097348-A1 Protein Formulation ARECOR LIMITED 2011-04-28 US claimed
EP-2283027-A2 PROTEIN FORMULATION Arecor Limited (GB) 2011-02-16 EP claimed
WO-2009133408-A2 PROTEIN FORMULATION ARECOR LIMITED (GB) 2009-11-05 WO claimed
US-9005611-B2 Protein formulation ARECOR LIMITED (GB) 2015-04-14 US disclosed
EP-2457590-B1 Protein formulation ARECOR LTD (GB) 2014-12-24 EP disclosed
EP-2457590-A2 Protein formulation Arecor Limited (GB) 2012-05-30 EP disclosed
US-20110097348-A1 Protein Formulation ARECOR LIMITED 2011-04-28 US disclosed
EP-2283027-A2 PROTEIN FORMULATION Arecor Limited (GB) 2011-02-16 EP disclosed
WO-2009133408-A2 PROTEIN FORMULATION ARECOR LIMITED (GB) 2009-11-05 WO disclosed